Dibutylamine → HCID 20505824、化合物
反応式
[CH2:1]([NH:5][CH2:6][CH2:7][CH2:8][CH3:9])[CH2:2][CH2:3][CH3:4].[Cl:10][C:11]1[C:19]([S:20](Cl)(=[O:22])=[O:21])=[CH:18][C:14]([C:15]([OH:17])=[O:16])=[CH:13][CH:12]=1>C(Cl)Cl>[Cl:10][C:11]1[C:19]([S:20](=[O:22])(=[O:21])[N:5]([CH2:6][CH2:7][CH2:8][CH3:9])[CH2:1][CH2:2][CH2:3][CH3:4])=[CH:18][C:14]([C:15]([OH:17])=[O:16])=[CH:13][CH:12]=1参加物
4
実験手順
To a solution of 3.9 g. (0.03 mole) of di-n-butylamine in 15 ml. of methylene chloride is added 2.5 g. (0.01 mole) of 4-chloro-5-chlorosulfonylbenzoic acid (J. Pharm. Pharmacol., 683 (1962), and the resulting reaction mixture allowed to stir at room temperature for 3 hrs. The solvent is removed under reduced pressure and the residue partitioned between 1N sodium hydroxide and diethyl ether. The aqueous phase is separated, acidified with 12N hydrochloric acid and the precipitated solid filtered and dried, 3.0 g., m.p. 93°-96° C. Recrystallization from ether-hexane provides the pure product, 2.5 g., m.p. 94.5°-96.5° C.
後処理
- custom, 683 (1962), and the resulting reaction mixture
- customThe solvent is removed under reduced pressure
- customthe residue partitioned between 1N sodium hydroxide and diethyl ether
- customThe aqueous phase is separated
- filtrationthe precipitated solid filtered
- customdried
- customRecrystallization from ether-hexane
- customprovides the pure product, 2.5 g
出典と根拠
- ORDレコード
- ord-9be74d7c051a441d88912fa99628712c
- 出典データセット
- uspto-grants-1978_11
- 特許番号
- US04124590
反応ノート
読み込み中…